Evaluation of Functional and Oncological Outcomes in Patients Undergoing Surgery for Differentiated Thyroid Carcinoma
Pacific Journal of Oncology & Immunotherapy · 2025
DOI: 10.70818/pjoi.v02i02.0174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pacific Journal of Oncology & Immunotherapy, 2025. Verfasst von Abdullah-Al- Mamun und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Differentiated thyroid carcinoma exhibits favorable survival outcomes; however, postoperative functional morbidity remains a significant concern, requiring integrated evaluation of oncological safety and functional preservation.
Objective
To evaluate functional and oncological outcomes following surgery for differentiated thyroid carcinoma, focusing on complication profiles, disease control, and associations between surgical extent and postoperative functional impairment.
Methods
A prospective observational study was conducted at the Department of ENT, 250 Bed Mohammad Ali Hospital, Bogura, from June 2023 to December 2024. A total of 102 patients underwent thyroid surgery. Variables included demographic data, tumor characteristics, surgical extent, hypocalcemia, recurrent laryngeal nerve injury, voice outcomes, recurrence, and disease-free survival. Statistical comparisons were performed using parametric and categorical analyses.
Results
Mean age was 41.8 ± 11.2 years; females constituted 72.5%. Papillary carcinoma represented 86.3%, and follicular carcinoma 13.7%. Total thyroidectomy was performed in 68.6%, lobectomy in 31.4%. Transient hypocalcemia occurred in 21.6% (mean serum calcium 7.9 ± 0.6 mg/dL), permanent hypocalcemia in 4.9%, and recurrent laryngeal nerve palsy in 6.9% (permanent 1.0%). Mean Voice Handicap Index score increased from 8.4 ± 3.1 preoperatively to 14.6 ± 4.8 postoperatively (p = 0.003). Complication rates were higher following total thyroidectomy than lobectomy (32.9% vs 12.5%; p = 0.01). Locoregional recurrence occurred in 7.8%, with one-year disease-free survival of 92.2%.
Conclusion
Surgical treatment of differentiated thyroid carcinoma achieves excellent oncological control; however, functional complications vary with surgical extent, underscoring the need for risk-adapted, function-preserving surgical strategies.
Zitieren
APA
Mamun, A., Islam, M. A., Islam, M. S., Hossain, M. B., Razzak, M. A., Yesmin, N., Sultana, N., & Abdullah, E. Z. (2025). Evaluation of Functional and Oncological Outcomes in Patients Undergoing Surgery for Differentiated Thyroid Carcinoma. Pacific Journal of Oncology & Immunotherapy. https://doi.org/10.70818/pjoi.v02i02.0174
Vancouver
Mamun A, Islam MA, Islam MS, Hossain MB, Razzak MA, Yesmin N, et al. Evaluation of Functional and Oncological Outcomes in Patients Undergoing Surgery for Differentiated Thyroid Carcinoma. Pacific Journal of Oncology & Immunotherapy. 2025. doi:10.70818/pjoi.v02i02.0174
BibTeX
@article{Mamun2025,
author = {Mamun, Abdullah-Al- and Islam, Md Asadul and Islam, Muhammad Saiful and Hossain, Mohammad Billal and Razzak, Md Abdur and Yesmin, Nasrin and Sultana, Nasrin and Abdullah, Effat Zahan},
title = {Evaluation of Functional and Oncological Outcomes in Patients Undergoing Surgery for Differentiated Thyroid Carcinoma},
journal = {Pacific Journal of Oncology & Immunotherapy},
year = {2025},
doi = {10.70818/pjoi.v02i02.0174}
}
EUVIMED